BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shafaattalab S, Li AY, Gunawan MG, Kim B, Jayousi F, Maaref Y, Song Z, Weiss JN, Solaro RJ, Qu Z, Tibbits GF. Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N. Front Cell Dev Biol 2021;9:787581. [PMID: 34977031 DOI: 10.3389/fcell.2021.787581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen H, Dong S, Ren M, Wang R. Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.949294] [Reference Citation Analysis]
2 Coscarella IL, Landim-Vieira M, Pinto JR, Chelko SP. Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics. Int J Mol Sci 2022;23:8753. [PMID: 35955883 DOI: 10.3390/ijms23158753] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Palandri C, Santini L, Argirò A, Margara F, Doste R, Bueno-Orovio A, Olivotto I, Coppini R. Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside. Drugs 2022;82:889-912. [PMID: 35696053 DOI: 10.1007/s40265-022-01728-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]